Evidence map›Paper›PMID 20031870›Full record

ArticleCirculation. Cardiovascular quality and outcomes2009

Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission.

Harlan M Krumholz, Angela R Merrill, Eric M Schone, Geoffrey C Schreiner, Jersey Chen, Elizabeth H Bradley, Yun Wang, Yongfei Wang, Zhenqiu Lin, Barry M Straube and 3 more

4 registry-linked trialsAbstract read
PubMed Publisher
In one paragraph

Article in Circulation. Cardiovascular quality and outcomes, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 258 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
258citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05759000 unknown statusstarted 2023, after this paper: background citation

The Effect of Early Inpatient Initiation of Dapagliflozin on the Health-related Quality of Life of Patients With Heart Failure With All Range of Ejection Fraction: a Local Registry

Ran2023Enrolled100Registered outcomes12Posted comparisons0ConditionsHeart FailureArmsdapagliflozin
Open the trial in the graph
NCT01673893 completednot on this mapstarted 2011, after this paper: background citation

ClearWay Rx Readmission Registry

TypeobservationalSponsorCardiovascular Institute of the South Clinical Research CorporationRan2011 to 2014Enrolled59ConditionsAcute Myocardial InfarctionArmsClearWay™ Rx catheter
NCT03457623 nacompletednot on this mapstarted 2017, after this paper: background citation

Medico-economic Evaluation of a "IsereADOM" Package of Services Versus Conventional Health and Social Monitoring, in the Care of a Population of People With Heart Failure in Isère.

TypeinterventionalSponsorUniversity Hospital, GrenobleRan2017 to 2019Enrolled66ConditionsHeart FailureArmsInnovative Supported
NCT04267744 naunknown statusnot on this mapstarted 2020, after this paper: background citation

Usability and Utility Assessment of Passive Remote Monitoring of Multiple Novel Indicators of Heart Failure

TypeinterventionalSponsorWashington University School of MedicineRan2020 to 2024Enrolled165ConditionsHeart FailureArmsMyia Health® remote patient monitoring unblinded treatment arm
3 · Its place in the literature

Who cites it

258 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

198 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Harlan M KrumholzSection of Cardiovascular Medicine and the Robert Wood Johnson Clinical Scholars Program, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06510, USA. harlan.krumholz@yale.edu
Angela R Merrill
Eric M Schone
Geoffrey C Schreiner
Jersey Chen
Elizabeth H Bradley
Yun Wang
Yongfei Wang
Zhenqiu Lin
Barry M Straube
Michael T Rapp
Sharon-Lise T Normand
Elizabeth E Drye

Funding

PHS HHS HHSM-500-2008-00020I (0001)PHS HHS HHSM-500-2008-00025I (0001)
6 · The paper itself

Abstract

backgroundIn 2009, the Centers for Medicare & Medicaid Services is publicly reporting hospital-level risk-standardized 30-day mortality and readmission rates after acute myocardial infarction (AMI) and heart failure (HF). We provide patterns of hospital performance, based on these measures. METHODS AND

resultsWe calculated the 30-day mortality and readmission rates for all Medicare fee-for-service beneficiaries ages 65 years or older with a primary diagnosis of AMI or HF, discharged between July 2005 and June 2008. We compared weighted risk-standardized mortality and readmission rates across Hospital Referral Regions and hospital structural characteristics. The median 30-day mortality rate was 16.6% for AMI (range, 10.9% to 24.9%; 25th to 75th percentile, 15.8% to 17.4%; 10th to 90th percentile, 14.7% to 18.4%) and 11.1% for HF (range, 6.6% to 19.8%; 25th to 75th percentile, 10.3% to 12.0%; 10th to 90th percentile, 9.4% to 13.1%). The median 30-day readmission rate was 19.9% for AMI (range, 15.3% to 29.4%; 25th to 75th percentile, 19.5% to 20.4%; 10th to 90th percentile, 18.8% to 21.1%) and 24.4% for HF (range, 15.9% to 34.4%; 25th to 75th percentile, 23.4% to 25.6%; 10th to 90th percentile, 22.3% to 27.0%). We observed geographic differences in performance across the country. Although there were some differences in average performance by hospital characteristics, there were high and low hospital performers among all types of hospitals.

conclusionsIn a recent 3-year period, 30-day risk-standardized mortality rates for AMI and HF varied among hospitals and across the country. The readmission rates were particularly high.

Indexed as

Hospital MortalityAgedAged, 80 and overFee-for-Service PlansGeographic Information SystemsHealth PolicyHealth Services AccessibilityHeart FailureHospitalsHumansMedicareMyocardial InfarctionPatient ReadmissionRisk FactorsUnited States

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.